Teladoc Health, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +23.2% | -93.1% | +894.2% | +24.2% | -22.0% | -81.5% | +474.4% | +8.6% | -11.6% | -89.2% | +579.5% | – | |
| – | +4.8% | -1.0% | -1.6% | -7.1% | -0.2% | -1.6% | -3.5% | +5.9% | +7.7% | -9.5% | +2.9% | – | |
| – | -11.6% | -9.6% | -0.5% | -19.1% | -19.3% | -8.4% | -11.2% | -23.9% | -6.4% | -8.2% | -36.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -8.7% | -577.7% | – | – | -25.6% | -476.9% | – | +78.5% | -82.9% | -968.9% | – | – | |
| – | -96.3% | -18.2% | +66.4% | +1,529.1% | -4.8% | +6.5% | -96.0% | +2,369.9% | -91.6% | -36.6% | -44.1% | – | |
| – | -3.0% | -2.7% | -21.9% | +12.3% | -4.8% | +315.8% | -51.6% | -18.4% | -29.6% | +6.4% | +13.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -135.0% | – | +117.3% | -81.7% | +194.8% | -62.6% | -71,612.7% | -99.3% | – | -321.8% | – | – | |
| – | +29.7% | -127.6% | – | +26.4% | -33.2% | -292.8% | – | – | +17.6% | -155.3% | – | – | |
| – | +89.4% | -94.0% | +1,016.6% | -8.9% | -28.8% | -127.8% | – | -24.6% | +25.3% | -90.8% | +711.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.